检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:刘晓珺[1] 刘北彦[1] 孔俊英[1] 王凤平[1] 孙辉[1] 谢文媛 王宏微 沈滨[4] 杜雅菊[5]
机构地区:[1]哈尔滨医科大学附属第二医院急诊医学科,黑龙江省哈尔滨市150081 [2]哈尔滨市红十字中心医院综合内科,黑龙江省哈尔滨市150076 [3]哈尔滨市红十字中心医院急诊科,黑龙江省哈尔滨市150076 [4]哈尔滨医科大学附属第二医院普外科,黑龙江省哈尔滨市150081 [5]哈尔滨医科大学附属第二医院消化科,黑龙江省哈尔滨市150081
出 处:《世界华人消化杂志》2014年第24期3625-3631,共7页World Chinese Journal of Digestology
基 金:黑龙江省教育厅科技研究基金资助项目;No.11541211~~
摘 要:目的:观察P38MAPK抑制剂SB203580对急性肝衰竭大鼠肝组织Caspase12蛋白表达及肝细胞凋亡的影响,探讨其对急性肝衰竭大鼠肝脏保护作用的机制.方法:72只健康Wistar大鼠随机分3组:对照组(注射生理盐水)、模型组(注射D-Gal/LPS)、抑制剂组(D-Gal/LPS+SB203580).按时间点分为3个亚组,每亚组8只.取血检测丙氨酸氨基转移酶(alanine aminotransferase,ALT)、总胆红素(total bilirubin,TBIL);HE染色观察肝组织病理学变化;免疫组织化学法检测Caspase12蛋白;二苯胺法检测细胞凋亡率.SPSS18.0统计分析.结果:抑制组12 h肝功、Caspase12蛋白表达和细胞凋亡率均低于模型组;18 h Caspase12蛋白表达与模型组差异无统计学意义,细胞凋亡率高于模型组;模型组12 h出现坏死,抑制组18 h出现坏死.结论:P38MAPK抑制剂SB203580能减少肝衰竭大鼠Caspase12蛋白表达和肝细胞凋亡率,减轻肝细胞坏死,对急性肝衰竭大鼠的肝脏具有保护作用.AIM: To observe the effect of P38 MAPK inhibitor SB203580 on Caspase12 protein expression and apoptosis of hepatocytes in rats with acute hepat-ic failure, and to explore the mechanism underly-ing its protective effect on acute hepatic failure. METHODS: Seventy-two healthy Wistar rats were randomly divided into three groups: a con-trol group(injected with normal saline), a model group(injected with D-galactosamine/lipopoly-saccharide, D-Gal/LPS), and an inhibitor group(injected with D-Gal/LPS + SB203580). Each group was further divided into three subgroups for testing at different time points, with 8 rats in each subgroup. Blood samples were collected for the determination of alanine aminotransfer-ase(ALT) and total bilirubin(TBIL). HE staining was performed to observe the liver pathologi-cal changes. Immunohistochemical assay was performed to detect the expression of Caspase12 protein. The diphenylamine method was used to detect the apoptosis rate. RESULTS: The liver function, Caspase12 pro-tein expression and apoptosis rate in the inhibi-tor group at 12 h were lower than those in the model group. Caspase12 protein expression at 18 h in the inhibitor group had no significant difference with that in the model group, while the apoptosis rate was significantly higher in the inhibitor group than in the model group. Necro-sis occurred in the model group at 12 h, and in the inhibitor group at 18 h. CONCLUSION: P38 MAPK inhibitor SB203580 can reduce the expression of Caspase12 protein, inhibit the endoplasmic reticulum stress-medi-ated hepatocyte apoptosis, reduce the necrosis of liver cells and play a protective effect against acute hepatic failure.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249